Evidence map›Paper›PMID 32436958›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

Intragenic Deletions of GNAS in Pseudohypoparathyroidism Type 1A Identify a New Region Affecting Methylation of Exon A/B.

Dong Li, Caleb Bupp, Michael E March, Hakon Hakonarson, Michael A Levine

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. UnusualJBMR plus · 2025
    Article
  2. Article
  3. EDIR: exome database of interspersed repeats.Bioinformatics (Oxford, England) · 2023
    Article
  4. Article
  5. Novel PTH Gene Mutations Causing Isolated Hypoparathyroidism.The Journal of clinical endocrinology and metabolism · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dong LiCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA.
Caleb BuppSpectrum Health, Grand Rapids, MI.
Michael E MarchCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA.
Hakon HakonarsonCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA.
Michael A LevineDepartment of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Children's Hospital of Philadelphia · USSpectrum Health · US

Funding

Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1R01DK112955 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Michael A. Levine, David R Weber · 2017 to 2026
$5.1M
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENER01DK056178 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI LEVINE, MICHAEL ALAN · 1999 to 2003
$1.6M
NIDDK NIH HHS R01 DK056178NIDDK NIH HHS R01 DK112955
6 · The paper itself

Abstract

contextPseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyroidism (PPHP) are caused by inactivating mutations in the exons of GNAS that encode the alpha-subunit of the stimulatory G protein (Gsα). In some cases abnormal methylation of exon A/B of GNAS, a hallmark of PHP1B, has been reported.

objectiveTo identify the underlying genetic basis for PHP1A/PPHP in patients in whom molecular defects were not detected by GNAS sequencing and microarray-based analysis of copy number variations.

methodsWhole genome sequencing (WGS) and pyrosequencing of differentially methylated regions (DMRs) of GNAS using genomic deoxyribonucleic acid from affected patients.

resultsWe identified 2 novel heterozygous GNAS deletions: a 6.4 kb deletion that includes exon 2 of GNAS in the first proband that was associated with normal methylation (57%) of exon A/B DMR, and a 1438 bp deletion in a second PHP1A patient that encompasses the promoter region and 5' untranslated region of Gsα transcripts, which was inherited from his mother with PPHP. This deletion was associated with reduced methylation (32%) of exon A/B DMR.

conclusionsWGS can detect exonic and intronic mutations, including deletions that are too small to be identified by microarray analysis, and therefore is more sensitive than other techniques for molecular analysis of PHP1A/PPHP. One of the deletions we identified led to reduced methylation of exon A/B DMR, further refining a region needed for normal imprinting of this DMR. We propose that deletion of this region can explain why some PHP1A patients have reduced of methylation of the exon A/B DMR.

Indexed as

DNA MethylationGene DeletionAdultChildChromograninsExonsFamilyFemaleGTP-Binding Protein alpha Subunits, GsHumansMaleMothersPseudohypoparathyroidismYoung AdultChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, GsGNASGNAS deletionPHP1Apseudohypoparathyroidism

Identifiers

PMID32436958
PMCPMC7947960
OpenAlexW3028537395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.